# ACACIA

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid8020676
Categories: beauty, cleaning, food, industrial, pharma
Functions: Adhesion/cohesion promoter, Deodorizer, Film former, Fragrance, Other, Processing aids not otherwise specified, Stabilizing agent, Viscosity modifier, cosmetics and various industrial applications, key ingredient in traditional lithography, paint production, used in printing
Identifier: DTXSID8020676

> ACACIA is used as adhesion/cohesion promoter / deodorizer. EPA CPDat observed this chemical in 540 composition records across product categories including Specialty occupational products, Laboratory supplies, Personal care. Assessed from 25 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 540 composition records across product categories including Specialty occupational products, Laboratory supplies, Personal care.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 540 composition records across product categories including Specialty occupational products, Laboratory supplies, Personal care. EPA CPDat classifies this chemical for functional uses including Film former, Deodorizer, Adhesion/cohesion promoter.
- US: inactive ingredient database — Route: BUCCAL; Dosage form: GUM, CHEWING; Maximum daily exposure: 280 mg
- US: inactive ingredient database — Route: BUCCAL; Dosage form: TABLET; Potency: 9.1 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: SUSPENSION; Potency: 1 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 20 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 64 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: LOZENGE; Maximum daily exposure: 108 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER; Potency: 800 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 7386 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 2 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SYRUP; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Potency: 70 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 121 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Potency: 156 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: 30 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Potency: 34.4 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 0.14 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 7 mg
- US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: TABLET; Potency: 9.1 mg
- US: marketed drug occurrence — FDA NDC lists this ingredient in 8 active drug products and 8 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as structurallydiverse.
- US: observed in branded food ingredient statements — Observed in 1 USDA branded foods including 1.75L Bloody Mary with Horseradish (MED).

_Assessed by Greenveil._